Fuse Vectors Raises $5.2M in Pre-Seed Funding

Fuse Vectors secures $5.2M to advance cell-free gene therapy technology

Gene therapy's biggest obstacle isn't science – it's manufacturing. While the field races forward with breakthrough treatments, production remains stuck in the 1980s, relying on unpredictable cell-based methods that make therapies costly and slow to develop. Fuse Vectors has announced $5.2 million in pre-seed financing led by HCVC to revolutionise gene therapy development with its cell-free viral vector technology.

Gene therapy manufacturing: Fuse Vectors secures US$5.2m - European Biotechnology Magazine

Fuse Vectors has secured US$5.2m in pre-seed financing to revolutionise gene therapy manufacturing with its cell-free viral vector technology. The Danish company is aiming to make treatments more accessible and cost-effective by streamlining production. The post Gene therapy manufacturing: Fuse Vectors secures US$5.2m appeared first on European Biotechnology Magazine.

Fuse Vectors secures USD $5.2m for gene therapy tech

Danish biotech firm Fuse Vectors has secured USD $5.2 million in pre-seed funding to advance its innovative cell-free gene therapy technology.

Fuse Vectors secures $5.2m to advance cell-free gene therapy technology, led by HCVC - Digital Health Technology News

Copenhagen, Denmark – 25 February 2025; Gene therapy’s biggest obstacle isn’t science – it’s manufacturing. While the field races forward with breakthrough treatments, production remains stuck in the 1980s, relying on unpredictable cell-based methods that make therapies costly and slow to develop. Today, Fuse Vectors announces $5.2 million in pre-seed financing led by HCVC to revolutionize gene therapy development with its cell-free viral vector…

Fuse Vectors Raises $5.2M in Pre-Seed Funding

Fuse Vectors, a Copenhagen, Denmark-based gene therapy company, raised $5.2M in Pre-Seed Funding. The round was led by HCVC. The company intends to use the funds to accelerate the development of its technology platform and pipeline of novel gene therapies. Co-founded by Benjamin Blaha and Jordan Turnbull, and Henrik Stage, Executive Chair, Fuse Vectors is […] The post Fuse Vectors Raises $5.2M in Pre-Seed Funding appeared first on FinSMEs.